Cécile Dupont Redon
Directeur Général chez BrightHeart SAS
Profil
Cécile Dupont - Principal, Program Director, MD Start Strategy
Cécile joined our MD Start team in 2019.
She is currently CEO of HEPTA Medical, and brings her operational and strategic expertise to Endoron to accelerate the development of the company's highly disruptive technology.
Prior to that, she was COO of Gradient Denervation Technologies, and director of clinical, regulatory and market access at SafeHeal, the first company created by MD Start II, where she managed the execution of the first-in-human study and regulatory approvals in the EU and US.
Prior to joining MD Start, Cécile held various clinical, marketing and regulatory positions in both mature and start-up medical device organizations in the fields of endoscopy, pulmonology, dermatology, surgery and diabetes care; for single and multi-use disposable products and capital equipment.
Cécile holds a bachelor’s degree in biomedical engineering from UTC (Université de Technologies de Compiègne) in France, Dalarna University (Sweden) and Favoloro University (Buenos Aires) in Argentina.
She also has a degree in corporate finance from HEC in Paris.
Postes actifs de Cécile Dupont Redon
| Sociétés | Poste | Début |
|---|---|---|
Sofinnova Partners SAS
 Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners SA (Sofinnova) is an independent venture capital firm established in 1972 and headquartered in Paris, France. Originally known as Sofinnova, the first venture capital firm created in France, the firm created a U.S. subsidiary in San Francisco in 1976. In 1997, both firms were bought out by their management teams, which become the majority shareholders of the new companies, Sofinnova Partners in Paris and Sofinnova Ventures in San Francisco. | Private Equity Investor | 01/01/2022 |
Hepta Medical SAS
 Hepta Medical SAS Information Technology ServicesTechnology Services Hepta Medical SAS provides medical technology solutions. The private company is based in Paris, France. The CEO of the French company is Cécile Dupont Redon. | Directeur Général | - |
BrightHeart SAS
 BrightHeart SAS Packaged SoftwareTechnology Services BrightHeart is an AI-based platform located in France that specializes in fetal ultrasound analysis. The French company's platform is designed to improve the detection of congenital heart defects. | Directeur Général | 01/11/2022 |
Formation de Cécile Dupont Redon
| Université de Technologie de Compiègne | Undergraduate Degree |
| École des Hautes Études Commerciales de Paris | Undergraduate Degree |
| Dalarna University of | Undergraduate Degree |
| Universidad Favaloro | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Sofinnova Partners SAS
Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners SA (Sofinnova) is an independent venture capital firm established in 1972 and headquartered in Paris, France. Originally known as Sofinnova, the first venture capital firm created in France, the firm created a U.S. subsidiary in San Francisco in 1976. In 1997, both firms were bought out by their management teams, which become the majority shareholders of the new companies, Sofinnova Partners in Paris and Sofinnova Ventures in San Francisco. | Finance |
Hepta Medical SAS
Hepta Medical SAS Information Technology ServicesTechnology Services Hepta Medical SAS provides medical technology solutions. The private company is based in Paris, France. The CEO of the French company is Cécile Dupont Redon. | Technology Services |
BrightHeart SAS
BrightHeart SAS Packaged SoftwareTechnology Services BrightHeart is an AI-based platform located in France that specializes in fetal ultrasound analysis. The French company's platform is designed to improve the detection of congenital heart defects. | Technology Services |
